The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Wong Shelly | SVP, FINANCE AND CAO | Sell(S) | 1K | $2.04 | $3K |
| Apr 16, 2026 | Knight Jeff E. | Chief Dev & Operating Officer | Grant(A) | 800K | — | $0 |
| Apr 16, 2026 | Klencke Barbara | Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Mar 19, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | Sell(S) | 903 | $2.17 | $2K |
| Mar 19, 2026 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 12K | $2.17 | $27K |
| Mar 3, 2026 | Klencke Barbara | Chief Medical Officer | Grant(A) | 700K | — | $0 |
| Feb 18, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | Sell(S) | 565 | $2.27 | $1K |
| Feb 17, 2026 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 2K | $2.27 | $5K |
| Feb 2, 2026 | Goodman Corey S | Director, 10% Owner | Buy(P) | 3.2M | $1.57 | $5.0M |
| Jan 26, 2026 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 912K | — | $0 |
| Jan 26, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | Grant(A) | 192K | — | $0 |
| Jan 26, 2026 | Shantharam Harish | Chief Financial Officer | Grant(A) | 303K | — | $0 |
| Jan 20, 2026 | Hemrajani Rekha | Director | Grant(A) | 40K | — | $0 |
| Jan 20, 2026 | Takimoto Chris H | Director | Grant(A) | 40K | — | $0 |
| Jan 20, 2026 | Curran Daniel J. | Director | Grant(A) | 17K | — | $0 |
| Jan 20, 2026 | Sandler Alan B. | Director | Grant(A) | 10K | — | $0 |
| Jan 20, 2026 | Garland J. Scott | Director | Grant(A) | 40K | — | $0 |
| Jan 20, 2026 | Goodman Corey S | Director, 10% Owner | Grant(A) | 40K | — | $0 |
| Jan 6, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | Sell(S) | 4K | $1.11 | $4K |
| Oct 14, 2025 | Shantharam Harish | Chief Financial Officer | Grant(A) | 199K | — | $0 |
| Oct 14, 2025 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 598K | — | $0 |
| Oct 14, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Grant(A) | 140K | — | $0 |
| Sep 17, 2025 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 71K | $1.08 | $77K |
| Sep 17, 2025 | Klencke Barbara | Director | Grant(A) | 300K | — | $0 |
| Sep 16, 2025 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 21K | $1.07 | $23K |
| Aug 18, 2025 | Shantharam Harish | Chief Financial Officer | Buy(P) | 75K | $0.78 | $59K |
| Aug 15, 2025 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 2K | $0.64 | $2K |
| Aug 15, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Sell(S) | 611 | $0.64 | $391 |
| Aug 12, 2025 | Curran Daniel J. | Director | Grant(A) | 40K | — | $0 |
| Jul 7, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Sell(S) | 2K | $0.45 | $905 |
| Jun 30, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Sell(S) | 2K | $0.43 | $659 |
| Apr 11, 2025 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 125K | — | $0 |
| Apr 11, 2025 | Shantharam Harish | Chief Financial Officer | Grant(A) | 125K | — | $0 |
| Apr 11, 2025 | Sandler Alan B. | Chief Medical Officer | Grant(A) | 125K | — | $0 |
| Apr 11, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Grant(A) | 90K | — | $0 |
| Mar 14, 2025 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 42K | — | $0 |
| Mar 14, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Grant(A) | 3K | — | $0 |
| Feb 19, 2025 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 2K | $1.15 | $2K |
| Feb 19, 2025 | Pons Jaume | PRESIDENT & CSO | Sell(S) | 1K | $1.15 | $2K |
| Feb 19, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Sell(S) | 550 | $1.15 | $633 |
| Jan 21, 2025 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 478K | — | $0 |
| Jan 21, 2025 | Pons Jaume | PRESIDENT & CSO | Grant(A) | 50K | — | $0 |
| Jan 21, 2025 | Sandler Alan B. | Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Jan 21, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Grant(A) | 112K | — | $0 |
| Jan 21, 2025 | Shantharam Harish | Chief Financial Officer | Grant(A) | 600K | — | $0 |
| Jan 21, 2025 | Klencke Barbara | Director | Grant(A) | 40K | — | $0 |
| Jan 21, 2025 | Takimoto Chris H | Director | Grant(A) | 40K | — | $0 |
| Jan 21, 2025 | Goodman Corey S | Director, 10% Owner | Grant(A) | 40K | — | $0 |
| Jan 21, 2025 | Garland J. Scott | Director | Grant(A) | 40K | — | $0 |
| Jan 21, 2025 | Hemrajani Rekha | Director | Grant(A) | 40K | — | $0 |
| Jan 6, 2025 | Pinto Shelly | Interim CFO | Sell(S) | 2K | $1.80 | $4K |
| Dec 30, 2024 | Pinto Shelly | Interim CFO | Sell(S) | 1K | $1.58 | $2K |
| Dec 30, 2024 | Pons Jaume | PRESIDENT & CSO | Sell(S) | 11K | $1.58 | $17K |
| Dec 2, 2024 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 200K | — | $0 |
| Dec 2, 2024 | Pinto Shelly | Interim CFO | Grant(A) | 150K | — | $0 |
| Dec 2, 2024 | Hemrajani Rekha | Director | Buy(P) | 30K | $1.55 | $47K |
| Nov 18, 2024 | Sandler Alan B. | Chief Medical Officer | Grant(A) | 600K | — | $0 |
| Aug 14, 2024 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 2K | $2.58 | $6K |
| Aug 14, 2024 | Pons Jaume | PRESIDENT & CSO | Sell(S) | 2K | $2.58 | $5K |
| Aug 14, 2024 | Garcia Peter S | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 761 | $2.58 | $2K |
| Aug 14, 2024 | Randolph Sophia | CHIEF MEDICAL OFFICER | Sell(S) | 1K | $2.58 | $4K |
| Aug 14, 2024 | Pinto Shelly | SVP, FINANCE AND CAO | Sell(S) | 564 | $2.58 | $1K |
| Aug 5, 2024 | Sandler Alan B. | Director | Grant(A) | 40K | — | $0 |
| Jul 11, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Sell(S) | 20K | $7.90 | $158K |
| Jul 11, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Option exercise(M) | 20K | $0.99 | $20K |
| Jul 11, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Option exercise(M) | 20K | — | $0 |
| Jul 5, 2024 | Pinto Shelly | SVP, FINANCE AND CAO | Sell(S) | 2K | $5.50 | $10K |
| Jul 1, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Sell(S) | 11K | $5.82 | $63K |
| Jul 1, 2024 | Randolph Sophia | CHIEF MEDICAL OFFICER, Director | Sell(S) | 3K | $5.82 | $19K |
| Jul 1, 2024 | Pinto Shelly | SVP, FINANCE AND CAO | Sell(S) | 1K | $5.82 | $8K |
| Jun 28, 2024 | Garcia Peter S | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 2K | $6.03 | $11K |
| Jun 13, 2024 | Goodman Corey S | Director, 10% Owner | Grant(A) | 20K | — | $0 |
| Jun 13, 2024 | Garland J. Scott | Director | Grant(A) | 20K | — | $0 |
| Jun 13, 2024 | Hemrajani Rekha | Director | Grant(A) | 20K | — | $0 |
| Jun 13, 2024 | Garcia Peter S | CHIEF FINANCIAL OFFICER | Buy(P) | 12K | $8.53 | $102K |
| Jun 4, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Option exercise(M) | 20K | $0.99 | $20K |
| Jun 4, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Sell(S) | 20K | $8.43 | $169K |
| Jun 4, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Option exercise(M) | 20K | — | $0 |
| May 13, 2024 | Randolph Sophia | CHIEF MEDICAL OFFICER, Director | Sell(S) | 10K | $15.82 | $161K |
| May 13, 2024 | Randolph Sophia | CHIEF MEDICAL OFFICER, Director | Sell(S) | 2K | $16.67 | $30K |
| May 6, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Option exercise(M) | 20K | $0.99 | $20K |
| May 6, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Sell(S) | 20K | $15.92 | $318K |
| May 6, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Option exercise(M) | 20K | — | $0 |
| Apr 16, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Option exercise(M) | 26K | $0.99 | $26K |
| Apr 16, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Sell(S) | 50K | $14.20 | $710K |
| Apr 16, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Option exercise(M) | 26K | — | $0 |
| Apr 4, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Sell(S) | 20K | $11.15 | $223K |
| Mar 14, 2024 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 4K | $11.31 | $50K |
| Feb 14, 2024 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 60K | — | $0 |
| Feb 14, 2024 | Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 190K | — | $0 |
| Feb 14, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Grant(A) | 30K | — | $0 |
| Feb 14, 2024 | Pons Jaume | PRESIDENT & CSO, Director | Grant(A) | 95K | — | $0 |
| Feb 14, 2024 | Randolph Sophia | CHIEF MEDICAL OFFICER, Director | Grant(A) | 30K | — | $0 |
| Feb 14, 2024 | Randolph Sophia | CHIEF MEDICAL OFFICER, Director | Grant(A) | 95K | — | $0 |
| Feb 14, 2024 | Garcia Peter S | CHIEF FINANCIAL OFFICER | Grant(A) | 25K | — | $0 |
| Feb 14, 2024 | Garcia Peter S | CHIEF FINANCIAL OFFICER | Grant(A) | 80K | — | $0 |
| Feb 14, 2024 | Pinto Shelly | SVP, FINANCE AND CAO | Grant(A) | 15K | — | $0 |
| Feb 14, 2024 | Pinto Shelly | SVP, FINANCE AND CAO | Grant(A) | 35K | — | $0 |
| Jan 4, 2024 | Pinto Shelly | SVP, Finance and CAO | Sell(S) | 3K | $13.60 | $37K |
| Dec 29, 2023 | Pons Jaume | President & CSO, Director | Sell(S) | 7K | $15.04 | $108K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-04-26 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).